BioSpace News Archive

Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to initiate a Phase 1 clinical trial for LYL797, Lyell’s first therapeutic candidate incorporating T-cell reprogramming technologies for the treatment of solid tumors.

Abeona Therapeutics Inc., a fully-integrated leader in gene and cell therapy, announced that it intends to offer and sell shares of its common stock and warrants to purchase common stock in an underwritten public offering pursuant to an existing shelf registration statement.

The Allen Institute named Rui Costa, D.V.M., Ph.D., as its next president and chief executive officer.

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab) today announced that, as planned and announced earlier this year, CEO Dale R. Pfost, PhD will assume the additional role of Chairman, subject to the approval of Chemomab’s shareholders, as is required under Israeli law.

Eisenhower Health is the FIRST hospital in California to be recognized by Edwards Lifesciences for completing its Edwards Benchmark program for the treatment of aortic stenosis in patients undergoing transcatheter aortic valve replacement (TAVR).

Inventiva (Euronext Paris and Nasdaq: IVA), today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, has been invited to present a corporate overview, followed by a Q&A session, and will engage, with Inventiva’s leadership team, in 1x1 investor meetings at the upcoming 40th Annual J.P. Morgan Annual Healthcare Conference.

HTG Molecular Diagnostics, Inc., a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board.

Trevi Therapeutics, Inc. (Nasdaq: TRVI) is a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions.

Surgical energy devices are used during open as well as minimally invasive surgeries for performing procedures such as tissue cutting, dissection, and coagulation.

Cannula is a hollow tube with a retractable, sharp inner core inserted into an artery or a vein, or another body cavity, to administer intravenous fluids and medicines, and obtain blood samples.